What This Bill Does · Plain English
GovGreed Synthesis · AI extraction
This bill requires the Secretary of Veterans Affairs to submit a report to Congress within 180 days after a psychedelic drug is approved or licensed by the FDA, detailing whether the VA will include that drug in its formulary and the justification for that decision.
Action Timeline
2024-09-06
Placed on the Union Calendar, Calendar No. 544.
2024-09-06
Reported by the Committee on Veterans' Affairs. H. Rept. 118-647.
2024-09-06
Reported by the Committee on Veterans' Affairs. H. Rept. 118-647.
2024-05-01
Ordered to be Reported by Voice Vote.
2024-05-01
Committee Consideration and Mark-up Session Held
2024-04-16
Forwarded by Subcommittee to Full Committee by Voice Vote.
2024-04-16
Subcommittee Consideration and Mark-up Session Held
2024-03-21
Subcommittee Hearings Held
2024-02-29
Referred to the Subcommittee on Health.
2024-02-14
Introduced in House
Frequently Asked Questions
Did HR.7347 pass?
HR.7347 did not pass and is no longer active. Final stage: FLOOR.
What does HR.7347 do?
This bill requires the Secretary of Veterans Affairs to submit a report to Congress within 180 days after a psychedelic drug is approved or licensed by the FDA, detailing whether the VA will include that drug in its formulary and the justification for that decision.
Full Bill Text
118 HR 7347 RH: To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs. U.S. House of Representatives 2024-09-06 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IB Union Calendar No. 544 118th CONGRESS 2d Session H. R. 7347 [Report No. 118–647] IN THE HOUSE OF REPRESENTATIVES February 14, 2024 Mr. Van Orden introduced the following bill; which was referred to the Committee on Veterans' Affairs September 6, 2024 Additional sponsor: Mr. Bergman September 6, 2024 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed A BILL To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs. 1. Reporting of determination of the Secretary of Veterans Affairs whether to include newly approved or licensed psychedelic drugs in the formulary of the Department of Veterans Affairs Chapter 81 of title 38, United States Code, is amended by inserting, after section 8125, the following new section (and conforming the table of sections at the beginning of such chapter accordingly): 8125A. Reporting of determination whether to include newly approved or licensed psychedelic drugs in the formulary of the Department Not later than 180 days after a psychedelic drug is approved under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ) or licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ), the Secretary shall submit to the Committees on Veterans’ Affairs of the Senate and House of Representatives a report regarding such drug, that includes— (1) the determination of the Secretary whether to include such drug in the formulary of the Department; and (2) the justification of the Secretary for such determination. . September 6, 2024 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed
Loading intelligence layer…